Survival analysis in patients with 
extrahepatic recurrence
Of the 227 patients, 78 had EHR (52 patients exhibited intrahepatic + EHR and 26 exhibited EHR alone). The log‐rank test showed that patients with EHR had significantly shorter RFS (median: 3 months vs. 18 months, HR: 3.639, Survival analysis and post‐recurrence treatments in patients with extrahepatic recurrence (EHR) versus without EHR (